Viking Therapeutics to Present at 2019 Cantor Global Healthcare Conference |
September 25, 2019 | September 2019 Bond Updates |
SAN DIEGO, Sept. 25, 2019 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will deliver a corporate... |
View more at: https://www.prnewswire.com:443/news-releases/viking-therapeutics-to-present-at-2019-cantor-global-healthcare-conference-300924576.html |
Related News |
|